Cape Town Lab
Discover Synexa’s biomarker and bioanalytical capabilities housed in Cape Town, South Africa.
Synexa Cape Town Lab Overview
Synexa’s Cape Town site offers broad, integrated biomarker and translational science capabilities to support both preclinical and clinical research. With extensive expertise across ligand binding bioanalysis, immunogenicity, cell biology, genomics and advanced tissue imaging, our scientists enable the generation of high‑quality, multi‑dimensional data across diverse therapeutic areas.
Operating under GCLP accreditation and certified to ‘Green Level’ by MyGreenLab, the laboratory is equipped with a wide range of technology platforms, including flow cytometry, ELISpot and FluoroSpot, MSD and ELISA, PCR and sequencing, and Olink proteomics. This depth of capability allows our scientists to deliver flexible, end‑to‑end solutions, helping customers gain deeper biological insights and progress programmes with confidence.
Cape Town Lab Services
Biomarkers
Synexa offers a range of biomarker services, including biomarker strategy, assay development, optimisation and validation, and high-quality biomarker analysis of clinical samples.
Translational Science
Our translational science capabilities connect discovery to clinical outcomes by generating integrated data and insights that link biological mechanisms to patient response.
Flow Cytometry
ELISpot
Synexa delivers sensitive ELISpot assays to quantify antigen-specific cellular responses, supporting immune monitoring and biomarker insights across preclinical and clinical studies with reliable, reproducible data.
Genomics
Our genomics capabilities deliver precise, high‑quality analysis to support translational and clinical studies, combining advanced techniques such as gene expression profiling, sequencing and qPCR to generate robust, actionable data.
Tissue Imaging
Our tissue imaging capabilities provide advanced, multi‑dimensional analysis to deliver precise insights into cellular and tissue architecture, enabling the interrogation of multiple targets in situ and a deeper understanding of spatial biology.
Extensive Translational Study Solutions
Our translational solutions generate clinically relevant insights by evaluating candidate therapeutics and biomarkers in fresh human samples from both healthy and diseased populations. Supported by access to an extensive clinical network and key opinion leaders (KOLs), we provide ethically sourced, disease‑relevant samples that better reflect real‑world biology.
By combining advanced analytical platforms with tailored study design, we deliver key insights into efficacy, safety and mechanism of action – reducing development risk and accelerating confident progression into clinical trials.
Explore our Other Labs
Manchester, UK
Located just 15 minutes from Manchester Airport, our Manchester laboratory serves as a key hub for clinical bioanalysis, with strong expertise in LC‑MS/MS, PK/TK/PD analysis, and regulated bioanalysis, supporting programmes from early development through to late-phase clinical trials.
Turku, Finland
Our Turku site holds a radiohandling licence, enabling advanced radiometric assays to support complex clinical and bioanalytical studies, alongside strong capabilities in biomarker analysis, immunoassays and cell‑based assays with deep expertise in immunology.
Improving the quality of human health.
Contact Us
Let’s discuss solutions to accelerate your therapeutic pipeline.
